We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

29 hedge funds and large institutions have $46.9M invested in ProQR Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 32 → 29 (-3)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

52% less capital invested

Capital invested by funds: $97.1M → $46.9M (-$50.1M)

Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$8.51M
2
BBA
Baker Bros. Advisors
New York
+$1.84M
3
SM
Sabby Management
Florida
+$560K
4
O
OrbiMed
New York
+$173K
5
FO
FT Options
Illinois
+$63.7K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.3M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$5.05M
3
Millennium Management
Millennium Management
New York
-$2.03M
4
JHIU
Janus Henderson Investors US
Colorado
-$1.73M
5
SFM
Sphera Funds Management
Israel
-$1.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$13.1M +$8.51M +1,673,070 +167%
O
2
OrbiMed
New York
$11.3M +$173K +33,946 +1%
BBA
3
Baker Bros. Advisors
New York
$6.59M +$1.84M +361,420 +37%
RG
4
Redmile Group
California
$2.7M -$22.8K -4,480 -0.8%
ClearBridge Investments
5
ClearBridge Investments
New York
$2.45M +$13.5K +2,653 +0.5%
Millennium Management
6
Millennium Management
New York
$2.32M -$2.03M -398,502 -46%
JHIU
7
Janus Henderson Investors US
Colorado
$2.09M -$1.73M -341,176 -44%
Franklin Resources
8
Franklin Resources
California
$1.51M – – –
Fidelity Investments
9
Fidelity Investments
Massachusetts
$1.16M -$10.3M -2,021,885 -89%
HCMT
10
Highland Capital Management (Texas)
Texas
$1.02M -$704K -138,548 -40%
AGA
11
Altrinsic Global Advisors
Connecticut
$1M – – –
SM
12
Sabby Management
Florida
$732K +$560K +110,063 +276%
Principal Financial Group
13
Principal Financial Group
Iowa
$382K – – –
Asset Management One
14
Asset Management One
Japan
$163K -$54.6K -10,747 -19%
TAM
15
Tocqueville Asset Management
New York
$105K – – –
CLM
16
ClearBridge LLC (Maryland)
Maryland
$88K – – –
FO
17
FT Options
Illinois
$61K +$63.7K +12,523 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$57K -$69.7K -13,713 -54%
M&T Bank
19
M&T Bank
New York
$55K – – –
SCM
20
Sterling Capital Management
North Carolina
$52K – – –
Wells Fargo
21
Wells Fargo
California
$52K +$36.2K +7,116 +206%
Walleye Trading
22
Walleye Trading
New York
$15K +$15.3K +3,000 New
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$13K +$10.2K +2,000 +382%
JP Morgan Chase
24
JP Morgan Chase
New York
$11K +$11.8K +2,315 New
Deutsche Bank
25
Deutsche Bank
Germany
$9K -$67.8K -13,336 -87%
1
2

PRQR Hedge Fund Activity: Q1 2016 in Review

29 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2016, worth a combined $46.9M — down 52% from $97.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PRQR and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Jennison Associates, adding an estimated $8.51M. The largest seller was Fidelity Investments, cutting an estimated $10.3M.

  • 29 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2016, down from 32 in Q4 2015.
  • Funds reported $46.9M of ProQR Therapeutics stock for Q1 2016, down 52% quarter-over-quarter.
  • 4 funds opened new ProQR Therapeutics positions in Q1 2016 and 7 closed out, a net change of -3 holders.
  • The largest ProQR Therapeutics buyer in Q1 2016 was Jennison Associates, an estimated $8.51M added.
  • The largest ProQR Therapeutics seller in Q1 2016 was Fidelity Investments, an estimated $10.3M sold.

Based on aggregated 13F filings for Q1 2016.